Medivir`s Fostrox + Lenvima Shows Promise In Liver Cancer
16 Sep 2024 //
PR NEWSWIRE
Fostrox + Lenvima® holds promise of greatly improved outcomes
27 Jun 2024 //
PR NEWSWIRE
Medivir Selects CRO For Phase 2b HCC Study With Fostrox + Lenvima
19 Jun 2024 //
PR NEWSWIRE
Medivir to Present Fostrox + Lenvima Data in HCC at ESMO GI
29 Apr 2024 //
PR NEWSWIRE
Medivir presents data on additive activity of fostrox with Lenvima or sorafenib
07 Sep 2023 //
PR NEWSWIRE
Medivir reports promising interim data
04 Sep 2023 //
PR NEWSWIRE
China approves Medivir’s patent application for Fostrox
19 Jun 2023 //
PHARMACEUTICAL TECHNOLOGY
Medivir to present data on efficacy of fostrox in combination with anti-PD1
17 Mar 2023 //
PR NEWSWIRE
First patient dosed in Ph 2a part of Medivir`s study with fostrox with Lenvima
14 Mar 2023 //
PR NEWSWIRE